The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Ishares Msci Italy Index Fund

NYSE: EWI
Last

(U.S.) $12.31

Today's change0.00 0.00%
Updated May 26 4:00 PM -4GMT. Delayed by at least 15 minutes.
 

Ishares Msci Italy Index Fund

NYSE: EWI
Last

(U.S.) $12.31

Today's change0.00 0.00%
Updated May 26 4:00 PM -4GMT. Delayed by at least 15 minutes.

Ishares Msci Italy Index Fund closed at (U.S.)$12.31.

Over the last five days, shares have gained 4.68%, but are down 10.41% for the last year to date. Shares have underperformed the S&P 500 by 18.98% during the last year.

Key company metrics

  • Open(U.S.) $0.00
  • Previous close(U.S.) $12.31
  • High--
  • Low--
  • Bid / Ask(U.S.) $12.13 / (U.S.) $12.46
  • YTD % change-10.41%
  • Volume0
  • Average volume (10-day)1,724,074
  • Average volume (1-month)1,843,416
  • Average volume (3-month)2,054,765
  • 52-week range(U.S.) $10.66 to (U.S.) $16.23
  • Beta1.39
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend(U.S.) $0.32
  • Dividend yield2.58%
  • Trailing EPS(U.S.) -$2.46
Updated May 26 4:00 PM -4GMT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
-553.49%

Ishares Msci Italy Index Fund has a net profit margin of -553.49%. Besides being negative, it is also below the industry average and implies that this company is not effective at turning revenues into bottom line profit.
Company Books

S&P TSX0.00%Sector:FinancialsIndustry:Investment Trusts

Latest Company News

Latest Press Releases

    No Press Release Results.
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2015Q4/2014Q2/2014Q4/2013
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedFeb 28, 201502/28/2015Aug 31, 201408/31/2014Feb 28, 201402/28/2014Aug 31, 201308/31/2013
Revenue829714
Total other revenue--------
Total revenue829714
Gross profit525513
Total cost of revenue3422
Total operating expense3422
Selling / general / administrative--------
Research & development--------
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income525513
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax-101-10320934
Income after tax-101-10320934
Income tax, total0000
Net income-101-10320934
Total adjustments to net income--------
Net income before extra. items-101-10320934
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-101-10320934
Inc. avail. to common incl. extra. items-101-10320934
Diluted net income-101-10320934
Dilution adjustment--------
Diluted weighted average shares611286766
Diluted EPS excluding extraordinary itemsvalue per share-1.65-0.813.120.52
Dividends per sharevalue per share0.100.240.100.25
Diluted normalized EPSvalue per share-1.65-0.813.120.52
R